| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master Protocol
|
Spicer, J.
|
|
|
26 |
2 |
p. 146-151
|
artikel
|
| 2 |
Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell Lung Cancer
|
Libby, Daniel M.
|
|
|
26 |
2 |
p. 116-123
|
artikel
|
| 3 |
Brief Report: Osimertinib Plus Capmatinib for Patients With MET-Altered EGFR-Mutant NSCLC Following Progression on Front Line Therapy
|
Elghawy, Omar
|
|
|
26 |
2 |
p. 158-163.e2
|
artikel
|
| 4 |
Clinical, Dosimetric and Radiomic Features Predictive of Lung Toxicity After (Chemo)Radiotherapy
|
Evin, Cécile
|
|
|
26 |
2 |
p. 93-103.e1
|
artikel
|
| 5 |
Correlation Between the Extent of N1 Lymph Node Station Examination and Prognosis in Stage I Non-small Cell Lung Cancer Patients: One Station is Insufficient
|
Liu, Junhong
|
|
|
26 |
2 |
p. e108-e117.e3
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
26 |
2 |
p. A1
|
artikel
|
| 7 |
Enhanced Recovery With Aggressive Ambulation Decreases Length of Stay in Lung Cancer Surgery
|
Park, Ju Ae
|
|
|
26 |
2 |
p. 140-145
|
artikel
|
| 8 |
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R Mutation
|
Zhou, Qing
|
|
|
26 |
2 |
p. 152-157.e1
|
artikel
|
| 9 |
Identification and Treatment of Lung Cancer Oncogenic Drivers in a Diverse Safety Net Setting
|
Narra, Kalyani
|
|
|
26 |
2 |
p. 83-92
|
artikel
|
| 10 |
Impact of Lung Biomarker Testing on Out-Of-Pocket Costs for Metastatic Non–Small-Cell Lung Cancer
|
Gharzai, Laila A.
|
|
|
26 |
2 |
p. e118-e125
|
artikel
|
| 11 |
Intraoperative Molecular Imaging With Pafolacianine: Histologic Characteristics of Identified Nodules
|
Sarkaria, Inderpal S.
|
|
|
26 |
2 |
p. 104-115
|
artikel
|
| 12 |
Lobectomy Is Not Associated With Improved Survival as Compared to Segmentectomy in Early-Stage Lung Cancer Patients With Visceral Pleural Invasion
|
Whitehorn, Gregory L.
|
|
|
26 |
2 |
p. e99-e107.e10
|
artikel
|
| 13 |
Outcomes Following Treatment for Progression in Patients Treated With Durvalumab Consolidation in LA-NSCLC
|
Stalker, Margaret
|
|
|
26 |
2 |
p. 124-130.e1
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
26 |
2 |
p. A3-A5
|
artikel
|
| 15 |
Tarlatamab Rechallenge After Grade 3 Cytokine Release Syndrome Leading to Tumor Regression in Two Weeks and Reopening of a Collapsed Lung: A Case Report
|
Schieber, Timothy
|
|
|
26 |
2 |
p. e126-e129
|
artikel
|
| 16 |
The Role of Medicaid Expansion on the Receipt of Adjuvant Chemotherapy in Patients With Lung Cancer
|
Rshaidat, Hamza
|
|
|
26 |
2 |
p. 131-139
|
artikel
|
Tijdschrift beschrijving